// App-Quantinova.ai

TCT-473 : A Randomized Comparison of Biodegradable Polymer- and Permanent Polymer-coated Platinum Chromium Everolimus-Eluting Coronary Stents in China: EVOLVE China Study

Researchers

Presenter

  • Yaling Han

Principal Investigators

  • Yuejin Yang

  • Guosheng Fu

  • Huiliang Liu

  • Fucheng Sun

  • Dominic J. Allocco

  • Xi Su

  • Tiemin Jiang

  • Wenyue Pang

  • Jiyan Chen

  • Zuyi Yuan

  • Hui Li

  • Haichang Wang

  • Tao Hong

Medical Centers

  • General Hospital of Shenyang Military Region, Shenyang, China

  • Shengjing Hospital Affiliated to China Medical University, Shenyang, China

  • First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xian, China

  • Beijing, China

  • The Af?liated Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, , China

  • The Affiliated Hospital of Medical College of Chinese People's Armed Police Force, Tianjin, China

  • Cardiovascular Institute and Fu Wai Hospital, Beijing, Beijing, China

  • Guangdong General Hospital, Guangzhou, China

  • The First Affiliated Hospital of the Forth Military Medical University, Xi'an, China

  • Wuhan Asia Heart Hospital,China

  • Beijing Affiliated Hospital of Armed Police Medical College, Beijing, China

Locations

  • China

Companies

  • Boston Scientific

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary artery lesions

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved